Skip to content

Clinical trials

Phase 2 Lymphoma, Large B-Cell, Diffuse trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 2 Country / region: Hungary Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20121
20141
20162
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Active, not recruiting2
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Debiopharm International SA1
Genmab1
ImmunoVaccine Technologies, Inc. (IMV Inc.)1
Karyopharm Therapeutics Inc1
MedImmune LLC1
Miltenyi Biomedicine GmbH1
MorphoSys AG1
Seagen Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse8
Lymphoma, Non-Hodgkin4
Lymphoma2
Hematologic Diseases1
Hematologic Neoplasms1
Immunoproliferative Disorders1
Leukemia, Hairy Cell1
Lymphatic Diseases1
Lymphoma, B-Cell1
Lymphoproliferative Disorders1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.